Oncology Drug Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0080810
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:7.12
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.12 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
SummaryDrugs used for oncology.
The global Oncology Drug market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2026, growing at a CAGR of xx% between 2019 and 2026.
This report studies the Oncology Drug market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oncology Drug in these regions, from 2014 to 2026, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck & Co.
Sanofi
Amgen Inc.
Abbvie
By the product type, the market is primarily split into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
By the end users/application, this report covers the following segments
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Oncology Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2026.
To understand the structure of Oncology Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oncology Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncology Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Oncology Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Oncology Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oncology Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Oncology Drug market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents
1 Oncology Drug Market Overview
1.1 Oncology Drug Product Overview
1.2 Oncology Drug Market Segment by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy
1.2.5 Others
1.3 Global Oncology Drug Market Size by Type
1.3.1 Global Oncology Drug Sales and Growth by Type
1.3.2 Global Oncology Drug Sales and Market Share by Type (2014-2019)
1.3.3 Global Oncology Drug Revenue and Market Share by Type (2014-2019)
1.3.4 Global Oncology Drug Price by Type (2014-2019)
2 Global Oncology Drug Market Competition by Company
2.1 Global Oncology Drug Sales and Market Share by Company (2014-2019)
2.2 Global Oncology Drug Revenue and Share by Company (2014-2019)
2.3 Global Oncology Drug Price by Company (2014-2019)
2.4 Global Top Players Oncology Drug Manufacturing Base Distribution, Sales Area, Product Types
2.5 Oncology Drug Market Competitive Situation and Trends
2.5.1 Oncology Drug Market Concentration Rate
2.5.2 Global Oncology Drug Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Oncology Drug Company Profiles and Sales Data
3.1 Roche Ltd
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Oncology Drug Product Category, Application and Specification
3.1.3 Roche Ltd Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Novartis AG
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Oncology Drug Product Category, Application and Specification
3.2.3 Novartis AG Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Bristol-Myers Squibb
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Oncology Drug Product Category, Application and Specification
3.3.3 Bristol-Myers Squibb Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Celgene Corporation
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Oncology Drug Product Category, Application and Specification
3.4.3 Celgene Corporation Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Johnson & Johnson
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Oncology Drug Product Category, Application and Specification
3.5.3 Johnson & Johnson Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Pfizer Inc.
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Oncology Drug Product Category, Application and Specification
3.6.3 Pfizer Inc. Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Astra Zenca Plc
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Oncology Drug Product Category, Application and Specification
3.7.3 Astra Zenca Plc Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Eli Lilly And Company.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Oncology Drug Product Category, Application and Specification
3.8.3 Eli Lilly And Company. Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Glaxosmithkline Plc
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Oncology Drug Product Category, Application and Specification
3.9.3 Glaxosmithkline Plc Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Merck & Co.
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Oncology Drug Product Category, Application and Specification
3.10.3 Merck & Co. Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Sanofi
3.12 Amgen Inc.
3.13 Abbvie
4 Oncology Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Oncology Drug Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Oncology Drug Sales and Revenue by Regions
4.2.1 Global Oncology Drug Sales and Market Share by Regions (2014-2019)
4.2.2 Global Oncology Drug Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Oncology Drug Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Oncology Drug Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Oncology Drug Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Oncology Drug Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Oncology Drug Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Oncology Drug Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Oncology Drug Application/End Users
5.1 Oncology Drug Segment by Application
5.1.1 Blood Cancer
5.1.2 Breast Cancer
5.1.3 gastrointestinal Tract Cancer
5.1.4 Prostate Cancer
5.1.5 Lung Cancer
5.1.6 Skin Cancer
5.2 Global Oncology Drug Product Segment by Application
5.2.1 Global Oncology Drug Sales by Application
5.2.2 Global Oncology Drug Sales and Market Share by Application (2014-2019)
6 Global Oncology Drug Market Forecast
6.1 Global Oncology Drug Sales, Revenue Forecast (2019-2025)
6.1.1 Global Oncology Drug Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Oncology Drug Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Oncology Drug Forecast by Regions
6.2.1 North America Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Oncology Drug Forecast by Type
6.3.1 Global Oncology Drug Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Chemotherapy Gowth Forecast
6.3.3 Targeted Therapy Gowth Forecast
6.4 Oncology Drug Forecast by Application
6.4.1 Global Oncology Drug Sales Forecast by Application (2019-2025)
6.4.2 Global Oncology Drug Forecast in Blood Cancer
6.4.3 Global Oncology Drug Forecast in Breast Cancer
7 Oncology Drug Upstream Raw Materials
7.1 Oncology Drug Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Oncology Drug Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Oncology Drug Product Picture
Figure Global Oncology Drug Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Oncology Drug Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Chemotherapy
Table Major Players of Chemotherapy
Figure Global Chemotherapy Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Targeted Therapy
Table Major Players of Targeted Therapy
Figure Global Targeted Therapy Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Immunotherapy
Table Major Players of Immunotherapy
Figure Global Immunotherapy Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Hormonal Therapy
Table Major Players of Hormonal Therapy
Figure Global Hormonal Therapy Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Oncology Drug Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Oncology Drug Sales (K Units) by Type (2014-2019)
Table Global Oncology Drug Sales Share (%) by Type (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Type (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Type in 2018
Table Global Oncology Drug Revenue (Million USD) by Type (2014-2019)
Table Global Oncology Drug Revenue Share (%) by Type (2014-2019)
Figure Global Oncology Drug Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Oncology Drug Revenue Market Share (%) by Type
Table Global Oncology Drug Price (USD/Unit) by Type (2014-2019)
Table Global Oncology Drug Sales (K Units) by Company (2014-2019)
Table Global Oncology Drug Sales Share (%) by Company (2014-2019)
Figure Global Oncology Drug Sales Share (%) by Company in 2018
Table Global Oncology Drug Revenue (Million USD) by Company (2014-2019)
Table Global Oncology Drug Revenue Share (%) by Company (2014-2019)
Figure Global Oncology Drug Revenue Share (%) by Company in 2018
Table Global Market Oncology Drug Average Price (USD/Unit) by Company (2014-2019)
Table Global Oncology Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Oncology Drug Top Players Product Category
Figure Global Oncology Drug Market Share (%) of Top 5 Players
Figure Global Oncology Drug Market Share (%) of Top 10 Players
Table Roche Ltd Basic Information List
Table Roche Ltd Oncology Drug Product Category, Application and Specification
Table Roche Ltd Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Roche Ltd Oncology Drug Sales Growth Rate (2014-2019)
Figure Roche Ltd Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Novartis AG Basic Information List
Figure Novartis AG Oncology Drug Product Category, Application and Specification
Table Novartis AG Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Novartis AG Oncology Drug Sales Growth Rate (2014-2019)
Figure Novartis AG Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Bristol-Myers Squibb Basic Information List
Figure Bristol-Myers Squibb Oncology Drug Product Category, Application and Specification
Table Bristol-Myers Squibb Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bristol-Myers Squibb Oncology Drug Sales Growth Rate (2014-2019)
Figure Bristol-Myers Squibb Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Celgene Corporation Basic Information List
Figure Celgene Corporation Oncology Drug Product Category, Application and Specification
Table Celgene Corporation Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Celgene Corporation Oncology Drug Sales Growth Rate (2014-2019)
Figure Celgene Corporation Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Johnson & Johnson Basic Information List
Figure Johnson & Johnson Oncology Drug Product Category, Application and Specification
Table Johnson & Johnson Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Johnson & Johnson Oncology Drug Sales Growth Rate (2014-2019)
Figure Johnson & Johnson Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Pfizer Inc. Basic Information List
Figure Pfizer Inc. Oncology Drug Product Category, Application and Specification
Table Pfizer Inc. Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Inc. Oncology Drug Sales Growth Rate (2014-2019)
Figure Pfizer Inc. Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Astra Zenca Plc Basic Information List
Figure Astra Zenca Plc Oncology Drug Product Category, Application and Specification
Table Astra Zenca Plc Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Astra Zenca Plc Oncology Drug Sales Growth Rate (2014-2019)
Figure Astra Zenca Plc Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Eli Lilly And Company. Basic Information List
Figure Eli Lilly And Company. Oncology Drug Product Category, Application and Specification
Table Eli Lilly And Company. Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eli Lilly And Company. Oncology Drug Sales Growth Rate (2014-2019)
Figure Eli Lilly And Company. Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Glaxosmithkline Plc Basic Information List
Figure Glaxosmithkline Plc Oncology Drug Product Category, Application and Specification
Table Glaxosmithkline Plc Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Glaxosmithkline Plc Oncology Drug Sales Growth Rate (2014-2019)
Figure Glaxosmithkline Plc Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Merck & Co. Basic Information List
Figure Merck & Co. Oncology Drug Product Category, Application and Specification
Table Merck & Co. Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Merck & Co. Oncology Drug Sales Growth Rate (2014-2019)
Figure Merck & Co. Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Sanofi Basic Information List
Table Amgen Inc. Basic Information List
Table Abbvie Basic Information List
Table Global Oncology Drug Market Size Comparison by Regions (2014-2025)
Figure North America Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Oncology Drug Sales (K Units) by Regions (2014-2019)
Table Global Oncology Drug Sales Market Share (%) by Regions (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Oncology Drug Sales Market Share (%) by Regions
Table Global Oncology Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Oncology Drug Revenue Market Share (%) by Regions (2014-2019)
Figure Global Oncology Drug Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Oncology Drug Revenue Market Share (%) by Regions
Table Global Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Oncology Drug Sales Growth Rate
Table North America Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Oncology Drug Sales (K Units)(2014-2019)
Figure United States Oncology Drug Revenue (Million USD)(2014-2019)
Figure Canada Oncology Drug Sales (K Units)(2014-2019)
Figure Canada Oncology Drug Revenue (Million USD)(2014-2019)
Figure Mexico Oncology Drug Sales (K Units)(2014-2019)
Figure Mexico Oncology Drug Revenue (Million USD)(2014-2019)
Figure Europe Oncology Drug Sales Growth Rate
Table Europe Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Oncology Drug Sales (K Units)(2014-2019)
Figure Germany Oncology Drug Revenue (Million USD) (2014-2019)
Figure UK Oncology Drug Sales (K Units)(2014-2019)
Figure UK Oncology Drug Revenue (Million USD)(2014-2019)
Figure France Oncology Drug Sales (K Units)(2014-2019)
Figure France Oncology Drug Revenue (Million USD)(2014-2019)
Figure Italy Oncology Drug Sales (K Units)(2014-2019)
Figure Italy Oncology Drug Revenue (Million USD)(2014-2019)
Figure Russia Oncology Drug Sales (K Units)(2014-2019)
Figure Russia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Turkey Oncology Drug Sales (K Units)(2014-2019)
Figure Turkey Oncology Drug Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Oncology Drug Sales Growth Rate
Table Asia-Pacific Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Oncology Drug Sales (K Units)(2014-2019)
Figure China Oncology Drug Revenue (Million USD)(2014-2019)
Figure Japan Oncology Drug Sales (K Units)(2014-2019)
Figure Japan Oncology Drug Revenue (Million USD)(2014-2019)
Figure Korea Oncology Drug Sales (K Units)(2014-2019)
Figure Korea Oncology Drug Revenue (Million USD)(2014-2019)
Figure Southeast Asia Oncology Drug Sales (K Units)(2014-2019)
Figure Southeast Asia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Indonesia Oncology Drug Sales (K Units)(2014-2019)
Figure Indonesia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Thailand Oncology Drug Sales (K Units)(2014-2019)
Figure Thailand Oncology Drug Revenue (Million USD)(2014-2019)
Figure Malaysia Oncology Drug Sales (K Units)(2014-2019)
Figure Malaysia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Philippines Oncology Drug Sales (K Units)(2014-2019)
Figure Philippines Oncology Drug Revenue (Million USD)(2014-2019)
Figure Vietnam Oncology Drug Sales (K Units)(2014-2019)
Figure Vietnam Oncology Drug Revenue (Million USD)(2014-2019)
Figure India Oncology Drug Sales (K Units)(2014-2019)
Figure India Oncology Drug Revenue (Million USD)(2014-2019)
Figure Australia Oncology Drug Sales (K Units)(2014-2019)
Figure Australia Oncology Drug Revenue (Million USD)(2014-2019)
Figure South America Oncology Drug Sales Growth Rate
Table South America Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Oncology Drug Sales (K Units)(2014-2019)
Figure Brazil Oncology Drug Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Oncology Drug Sales Growth Rate
Table Middle East and Africa Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Oncology Drug Sales (K Units)(2014-2019)
Figure North Africa Oncology Drug Revenue (Million USD)(2014-2019)
Figure GCC Countries Oncology Drug Sales (K Units)(2014-2019)
Figure GCC Countries Oncology Drug Revenue (Million USD)(2014-2019)
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure gastrointestinal Tract Cancer Examples
Figure Prostate Cancer Examples
Figure Lung Cancer Examples
Figure Skin Cancer Examples
Table Global Oncology Drug Sales (K Units) Comparison by Application (2014-2025)
Table Global Oncology Drug Sales (K Units) by Application (2014-2019)
Table Global Oncology Drug Sales Share (%) by Application (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Application (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Application in 2018
Figure Global Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Oncology Drug Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Oncology Drug Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Oncology Drug Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Oncology Drug Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Oncology Drug Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Oncology Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Oncology Drug Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Chemotherapy Sales Growth Forecast
Figure Targeted Therapy Sales Growth Forecast
Table Global Oncology Drug Sales (K Units) Forecast by Application (2019-2025)
Figure Global Oncology Drug Sales Forecast by Application (2019-2025)
Figure Global Oncology Drug Sales (K Units) Forecast in Blood Cancer
Figure Global Oncology Drug Sales (K Units) Forecast in Breast Cancer
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Oncology Drug Manufacturing Cost Structure
Figure Oncology Drug Industrial Chain Analysis
Table Distributors List
Table Oncology Drug Downstream Customers
1 Oncology Drug Market Overview
1.1 Oncology Drug Product Overview
1.2 Oncology Drug Market Segment by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy
1.2.5 Others
1.3 Global Oncology Drug Market Size by Type
1.3.1 Global Oncology Drug Sales and Growth by Type
1.3.2 Global Oncology Drug Sales and Market Share by Type (2014-2019)
1.3.3 Global Oncology Drug Revenue and Market Share by Type (2014-2019)
1.3.4 Global Oncology Drug Price by Type (2014-2019)
2 Global Oncology Drug Market Competition by Company
2.1 Global Oncology Drug Sales and Market Share by Company (2014-2019)
2.2 Global Oncology Drug Revenue and Share by Company (2014-2019)
2.3 Global Oncology Drug Price by Company (2014-2019)
2.4 Global Top Players Oncology Drug Manufacturing Base Distribution, Sales Area, Product Types
2.5 Oncology Drug Market Competitive Situation and Trends
2.5.1 Oncology Drug Market Concentration Rate
2.5.2 Global Oncology Drug Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Oncology Drug Company Profiles and Sales Data
3.1 Roche Ltd
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Oncology Drug Product Category, Application and Specification
3.1.3 Roche Ltd Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Novartis AG
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Oncology Drug Product Category, Application and Specification
3.2.3 Novartis AG Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Bristol-Myers Squibb
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Oncology Drug Product Category, Application and Specification
3.3.3 Bristol-Myers Squibb Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Celgene Corporation
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Oncology Drug Product Category, Application and Specification
3.4.3 Celgene Corporation Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Johnson & Johnson
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Oncology Drug Product Category, Application and Specification
3.5.3 Johnson & Johnson Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Pfizer Inc.
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Oncology Drug Product Category, Application and Specification
3.6.3 Pfizer Inc. Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Astra Zenca Plc
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Oncology Drug Product Category, Application and Specification
3.7.3 Astra Zenca Plc Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Eli Lilly And Company.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Oncology Drug Product Category, Application and Specification
3.8.3 Eli Lilly And Company. Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Glaxosmithkline Plc
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Oncology Drug Product Category, Application and Specification
3.9.3 Glaxosmithkline Plc Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Merck & Co.
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Oncology Drug Product Category, Application and Specification
3.10.3 Merck & Co. Oncology Drug Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Sanofi
3.12 Amgen Inc.
3.13 Abbvie
4 Oncology Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Oncology Drug Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Oncology Drug Sales and Revenue by Regions
4.2.1 Global Oncology Drug Sales and Market Share by Regions (2014-2019)
4.2.2 Global Oncology Drug Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Oncology Drug Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Oncology Drug Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Oncology Drug Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Oncology Drug Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Oncology Drug Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Oncology Drug Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Oncology Drug Application/End Users
5.1 Oncology Drug Segment by Application
5.1.1 Blood Cancer
5.1.2 Breast Cancer
5.1.3 gastrointestinal Tract Cancer
5.1.4 Prostate Cancer
5.1.5 Lung Cancer
5.1.6 Skin Cancer
5.2 Global Oncology Drug Product Segment by Application
5.2.1 Global Oncology Drug Sales by Application
5.2.2 Global Oncology Drug Sales and Market Share by Application (2014-2019)
6 Global Oncology Drug Market Forecast
6.1 Global Oncology Drug Sales, Revenue Forecast (2019-2025)
6.1.1 Global Oncology Drug Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Oncology Drug Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Oncology Drug Forecast by Regions
6.2.1 North America Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Oncology Drug Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Oncology Drug Forecast by Type
6.3.1 Global Oncology Drug Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Chemotherapy Gowth Forecast
6.3.3 Targeted Therapy Gowth Forecast
6.4 Oncology Drug Forecast by Application
6.4.1 Global Oncology Drug Sales Forecast by Application (2019-2025)
6.4.2 Global Oncology Drug Forecast in Blood Cancer
6.4.3 Global Oncology Drug Forecast in Breast Cancer
7 Oncology Drug Upstream Raw Materials
7.1 Oncology Drug Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Oncology Drug Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure Oncology Drug Product Picture
Figure Global Oncology Drug Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Oncology Drug Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Chemotherapy
Table Major Players of Chemotherapy
Figure Global Chemotherapy Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Targeted Therapy
Table Major Players of Targeted Therapy
Figure Global Targeted Therapy Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Immunotherapy
Table Major Players of Immunotherapy
Figure Global Immunotherapy Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Hormonal Therapy
Table Major Players of Hormonal Therapy
Figure Global Hormonal Therapy Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Oncology Drug Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Oncology Drug Sales (K Units) by Type (2014-2019)
Table Global Oncology Drug Sales Share (%) by Type (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Type (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Type in 2018
Table Global Oncology Drug Revenue (Million USD) by Type (2014-2019)
Table Global Oncology Drug Revenue Share (%) by Type (2014-2019)
Figure Global Oncology Drug Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Oncology Drug Revenue Market Share (%) by Type
Table Global Oncology Drug Price (USD/Unit) by Type (2014-2019)
Table Global Oncology Drug Sales (K Units) by Company (2014-2019)
Table Global Oncology Drug Sales Share (%) by Company (2014-2019)
Figure Global Oncology Drug Sales Share (%) by Company in 2018
Table Global Oncology Drug Revenue (Million USD) by Company (2014-2019)
Table Global Oncology Drug Revenue Share (%) by Company (2014-2019)
Figure Global Oncology Drug Revenue Share (%) by Company in 2018
Table Global Market Oncology Drug Average Price (USD/Unit) by Company (2014-2019)
Table Global Oncology Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Oncology Drug Top Players Product Category
Figure Global Oncology Drug Market Share (%) of Top 5 Players
Figure Global Oncology Drug Market Share (%) of Top 10 Players
Table Roche Ltd Basic Information List
Table Roche Ltd Oncology Drug Product Category, Application and Specification
Table Roche Ltd Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Roche Ltd Oncology Drug Sales Growth Rate (2014-2019)
Figure Roche Ltd Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Novartis AG Basic Information List
Figure Novartis AG Oncology Drug Product Category, Application and Specification
Table Novartis AG Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Novartis AG Oncology Drug Sales Growth Rate (2014-2019)
Figure Novartis AG Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Bristol-Myers Squibb Basic Information List
Figure Bristol-Myers Squibb Oncology Drug Product Category, Application and Specification
Table Bristol-Myers Squibb Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bristol-Myers Squibb Oncology Drug Sales Growth Rate (2014-2019)
Figure Bristol-Myers Squibb Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Celgene Corporation Basic Information List
Figure Celgene Corporation Oncology Drug Product Category, Application and Specification
Table Celgene Corporation Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Celgene Corporation Oncology Drug Sales Growth Rate (2014-2019)
Figure Celgene Corporation Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Johnson & Johnson Basic Information List
Figure Johnson & Johnson Oncology Drug Product Category, Application and Specification
Table Johnson & Johnson Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Johnson & Johnson Oncology Drug Sales Growth Rate (2014-2019)
Figure Johnson & Johnson Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Pfizer Inc. Basic Information List
Figure Pfizer Inc. Oncology Drug Product Category, Application and Specification
Table Pfizer Inc. Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer Inc. Oncology Drug Sales Growth Rate (2014-2019)
Figure Pfizer Inc. Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Astra Zenca Plc Basic Information List
Figure Astra Zenca Plc Oncology Drug Product Category, Application and Specification
Table Astra Zenca Plc Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Astra Zenca Plc Oncology Drug Sales Growth Rate (2014-2019)
Figure Astra Zenca Plc Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Eli Lilly And Company. Basic Information List
Figure Eli Lilly And Company. Oncology Drug Product Category, Application and Specification
Table Eli Lilly And Company. Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eli Lilly And Company. Oncology Drug Sales Growth Rate (2014-2019)
Figure Eli Lilly And Company. Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Glaxosmithkline Plc Basic Information List
Figure Glaxosmithkline Plc Oncology Drug Product Category, Application and Specification
Table Glaxosmithkline Plc Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Glaxosmithkline Plc Oncology Drug Sales Growth Rate (2014-2019)
Figure Glaxosmithkline Plc Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Merck & Co. Basic Information List
Figure Merck & Co. Oncology Drug Product Category, Application and Specification
Table Merck & Co. Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Merck & Co. Oncology Drug Sales Growth Rate (2014-2019)
Figure Merck & Co. Oncology Drug Sales Global Market Share (%)(2014-2019)
Table Sanofi Basic Information List
Table Amgen Inc. Basic Information List
Table Abbvie Basic Information List
Table Global Oncology Drug Market Size Comparison by Regions (2014-2025)
Figure North America Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Oncology Drug Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Oncology Drug Sales (K Units) by Regions (2014-2019)
Table Global Oncology Drug Sales Market Share (%) by Regions (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Oncology Drug Sales Market Share (%) by Regions
Table Global Oncology Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Oncology Drug Revenue Market Share (%) by Regions (2014-2019)
Figure Global Oncology Drug Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Oncology Drug Revenue Market Share (%) by Regions
Table Global Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Oncology Drug Sales Growth Rate
Table North America Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Oncology Drug Sales (K Units)(2014-2019)
Figure United States Oncology Drug Revenue (Million USD)(2014-2019)
Figure Canada Oncology Drug Sales (K Units)(2014-2019)
Figure Canada Oncology Drug Revenue (Million USD)(2014-2019)
Figure Mexico Oncology Drug Sales (K Units)(2014-2019)
Figure Mexico Oncology Drug Revenue (Million USD)(2014-2019)
Figure Europe Oncology Drug Sales Growth Rate
Table Europe Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Oncology Drug Sales (K Units)(2014-2019)
Figure Germany Oncology Drug Revenue (Million USD) (2014-2019)
Figure UK Oncology Drug Sales (K Units)(2014-2019)
Figure UK Oncology Drug Revenue (Million USD)(2014-2019)
Figure France Oncology Drug Sales (K Units)(2014-2019)
Figure France Oncology Drug Revenue (Million USD)(2014-2019)
Figure Italy Oncology Drug Sales (K Units)(2014-2019)
Figure Italy Oncology Drug Revenue (Million USD)(2014-2019)
Figure Russia Oncology Drug Sales (K Units)(2014-2019)
Figure Russia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Turkey Oncology Drug Sales (K Units)(2014-2019)
Figure Turkey Oncology Drug Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Oncology Drug Sales Growth Rate
Table Asia-Pacific Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Oncology Drug Sales (K Units)(2014-2019)
Figure China Oncology Drug Revenue (Million USD)(2014-2019)
Figure Japan Oncology Drug Sales (K Units)(2014-2019)
Figure Japan Oncology Drug Revenue (Million USD)(2014-2019)
Figure Korea Oncology Drug Sales (K Units)(2014-2019)
Figure Korea Oncology Drug Revenue (Million USD)(2014-2019)
Figure Southeast Asia Oncology Drug Sales (K Units)(2014-2019)
Figure Southeast Asia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Indonesia Oncology Drug Sales (K Units)(2014-2019)
Figure Indonesia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Thailand Oncology Drug Sales (K Units)(2014-2019)
Figure Thailand Oncology Drug Revenue (Million USD)(2014-2019)
Figure Malaysia Oncology Drug Sales (K Units)(2014-2019)
Figure Malaysia Oncology Drug Revenue (Million USD)(2014-2019)
Figure Philippines Oncology Drug Sales (K Units)(2014-2019)
Figure Philippines Oncology Drug Revenue (Million USD)(2014-2019)
Figure Vietnam Oncology Drug Sales (K Units)(2014-2019)
Figure Vietnam Oncology Drug Revenue (Million USD)(2014-2019)
Figure India Oncology Drug Sales (K Units)(2014-2019)
Figure India Oncology Drug Revenue (Million USD)(2014-2019)
Figure Australia Oncology Drug Sales (K Units)(2014-2019)
Figure Australia Oncology Drug Revenue (Million USD)(2014-2019)
Figure South America Oncology Drug Sales Growth Rate
Table South America Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Oncology Drug Sales (K Units)(2014-2019)
Figure Brazil Oncology Drug Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Oncology Drug Sales Growth Rate
Table Middle East and Africa Oncology Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Oncology Drug Sales (K Units)(2014-2019)
Figure North Africa Oncology Drug Revenue (Million USD)(2014-2019)
Figure GCC Countries Oncology Drug Sales (K Units)(2014-2019)
Figure GCC Countries Oncology Drug Revenue (Million USD)(2014-2019)
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure gastrointestinal Tract Cancer Examples
Figure Prostate Cancer Examples
Figure Lung Cancer Examples
Figure Skin Cancer Examples
Table Global Oncology Drug Sales (K Units) Comparison by Application (2014-2025)
Table Global Oncology Drug Sales (K Units) by Application (2014-2019)
Table Global Oncology Drug Sales Share (%) by Application (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Application (2014-2019)
Figure Global Oncology Drug Sales Market Share (%) by Application in 2018
Figure Global Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Oncology Drug Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Oncology Drug Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Oncology Drug Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Oncology Drug Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Oncology Drug Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Oncology Drug Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Oncology Drug Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Oncology Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Oncology Drug Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Chemotherapy Sales Growth Forecast
Figure Targeted Therapy Sales Growth Forecast
Table Global Oncology Drug Sales (K Units) Forecast by Application (2019-2025)
Figure Global Oncology Drug Sales Forecast by Application (2019-2025)
Figure Global Oncology Drug Sales (K Units) Forecast in Blood Cancer
Figure Global Oncology Drug Sales (K Units) Forecast in Breast Cancer
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Oncology Drug Manufacturing Cost Structure
Figure Oncology Drug Industrial Chain Analysis
Table Distributors List
Table Oncology Drug Downstream Customers
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"